Investing.com - BIOLASE reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
BIOLASE announced earnings per share of $-1.1000 on revenue of $12.01M. Analysts polled by Investing.com anticipated EPS of $-0.6300 on revenue of $10.53M.
BIOLASE shares are down 28.35% from the beginning of the year, still down 90.03% from its 52 week high of $15.75 set on November 10, 2021.
BIOLASE shares gained 3.18% in after-hours trade following the report.
BIOLASE follows other major Healthcare sector earnings this month
BIOLASE's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar